scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0306-4522(99)00049-4 |
P698 | PubMed publication ID | 10426541 |
P2093 | author name string | Hunt GE | |
McGregor IS | |||
Stephenson CP | |||
Topple AN | |||
P2860 | cites work | MDMA (ecstasy) and the rave: a review | Q30471049 |
Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex | Q30500018 | ||
Emotional memory and psychopathology | Q30500022 | ||
An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat | Q34237223 | ||
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy') | Q34327848 | ||
Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex | Q34385607 | ||
Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits | Q34467867 | ||
The human amygdala in social judgment. | Q34471409 | ||
Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") | Q34720985 | ||
Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices | Q35007597 | ||
Neurotoxic amphetamine analogues: effects in monkeys and implications for humans | Q35328693 | ||
Animal models of serotonin behavior. | Q38004430 | ||
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug | Q38555431 | ||
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). | Q40483217 | ||
Fos: an immediate-early transcription factor in neurons | Q40541836 | ||
Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway | Q73049351 | ||
Role of dopamine in behavioral effects of serotonin microinjected into rat striatum | Q73109617 | ||
Identification of rat brainstem multisynaptic connections to the oral motor nuclei using pseudorabies virus. I. Masticatory muscle motor systems | Q74293254 | ||
Localization of the micturition reflex center at dorsolateral pontine tegmentum of the rat | Q84235229 | ||
The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system | Q40665328 | ||
Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing | Q40678302 | ||
Hyperthermia induces c-fos expression in the preoptic area | Q40714203 | ||
Functional neuroanatomy and neuropathology of the human hypothalamus. | Q40917094 | ||
Serotonergic functions in arousal and motor activity | Q41097159 | ||
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") | Q41110153 | ||
Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives | Q41150965 | ||
Multiple serotonin receptors: too many, not enough, or just the right number? | Q41629871 | ||
Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala | Q41639943 | ||
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. | Q42489289 | ||
5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus | Q42527746 | ||
The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine | Q42595162 | ||
Drugs of abuse and immediate-early genes in the forebrain | Q43070951 | ||
MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids | Q43310986 | ||
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine | Q44311355 | ||
The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat. | Q44806025 | ||
A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. | Q45071429 | ||
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release | Q46176249 | ||
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use | Q46423477 | ||
Induction of Fos protein by 3,4- methylenedioxymethamphetamine (Ecstasy) in rat brain: regional differences in pharmacological manipulation. | Q47686242 | ||
Low-dose MDMA ("ecstasy") induces vasopressin secretion | Q47943432 | ||
Methysergide potentiates the hyperactivity produced by MDMA in rats | Q48108357 | ||
Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings | Q48355353 | ||
Possible neural substrates of beer-craving in rats | Q48384747 | ||
The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain | Q48418889 | ||
The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain | Q48447583 | ||
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin | Q48456238 | ||
Fos expression in rat pontine tegmental neurons following activation of the medial preoptic area | Q48460610 | ||
MDMA elicits behavioral and neurochemical sensitization in rats | Q48478397 | ||
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems | Q48502115 | ||
Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons | Q48538052 | ||
Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. | Q48580623 | ||
Getting the brain's attention | Q48613454 | ||
3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801 | Q48766799 | ||
Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers | Q48788983 | ||
A differential neural response in the human amygdala to fearful and happy facial expressions | Q48886837 | ||
Effect of chronic dexfenfluramine on Fos in rat brain | Q48960384 | ||
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine | Q48967363 | ||
Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine | Q49030374 | ||
3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan | Q49050896 | ||
MDMA ("ecstasy") and panic disorder: induction by a single dose | Q51147500 | ||
CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. | Q51531414 | ||
Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration. | Q51603345 | ||
The psychological and physiological effects of MDMA on normal volunteers. | Q52137476 | ||
Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. | Q52196710 | ||
Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage. | Q52239530 | ||
A sensitive double immunostaining protocol for Fos-immunoreactive neurons | Q58852492 | ||
Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat | Q69374859 | ||
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat | Q69378649 | ||
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain | Q69895629 | ||
Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels | Q70850535 | ||
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats | Q70853211 | ||
Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA) | Q71013644 | ||
P-chloroamphetamine induces c-fos in rat brain: a study of serotonin2A/2C receptor function | Q71323717 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 13 | |
P304 | page(s) | 1011-1023 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | |
P478 | volume | 92 |
Q51064624 | "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. |
Q51073688 | (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. |
Q43261577 | A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice |
Q38271820 | A potential role for the paraventricular nucleus of the thalamus in mediating individual variation in Pavlovian conditioned responses. |
Q48876145 | Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain |
Q36012516 | Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes. |
Q48156136 | Ascorbic acid and α-tocopherol supplement starting prenatally enhances the resistance of nucleus tractus solitarius neurons to hypobaric hypoxic challenge |
Q30466934 | Behavioral effects of MDMA ('ecstasy') on adult zebrafish. |
Q33678859 | Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats |
Q40168155 | Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. |
Q45194190 | Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect |
Q43984335 | Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulation. |
Q48865378 | Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA. |
Q48377471 | Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury |
Q40541816 | Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain |
Q44225214 | Effect of 5-HT1A receptor-mediated serotonin augmentation on Fos immunoreactivity in rat brain |
Q44823747 | Effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') on the jaw-opening reflex and on the alpha-adrenoceptors which regulate this reflex in the anesthetized rat. |
Q48250458 | Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination |
Q36645266 | Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats. |
Q44487751 | Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: a comparative study using real-time quantitative polymerase chain reaction in rat brain |
Q36967668 | Functional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse |
Q42256324 | Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. |
Q43832354 | Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). |
Q44050776 | Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion |
Q34673747 | Lesions of the fasciculus retroflexus alter footshock-induced cFos expression in the mesopontine rostromedial tegmental area of rats |
Q37149027 | MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology |
Q44829465 | MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission |
Q48844071 | Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats |
Q58045855 | Metabolism of [14C]-5-chloro-1,3-benzodioxol-4-amine in male Wistar-derived rats following intraperitoneal administration |
Q46478879 | Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats |
Q42460934 | Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. |
Q34442379 | Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure |
Q31378921 | Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum |
Q30398111 | Sex differences in MDMA-induced toxicity in Sprague-Dawley rats. |
Q92204594 | The cerebellum under stress |
Q43807460 | The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. |
Q44454418 | The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats |
Q38954037 | The heat is on: Molecular mechanisms of drug-induced hyperthermia |
Q35986088 | The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. |
Q47298965 | Transient inactivation of the paraventricular nucleus of the thalamus enhances cue-induced reinstatement in goal-trackers, but not sign-trackers. |
Search more.